EP3564357
Bakteríumeðferð við Clostridium difficile ristilbólgu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
1.2.2011EP published:
6.4.2022EP application number:
19176151.9
EP translation filed:
3.6.2022Grant published:
15.7.2022EPO information:
European Patent Register
Max expiry date:
31.1.2031Expiry date:
31.1.2027Next due date:
28.2.2027
Title in English:
BACTERIOTHERAPY FOR CLOSTRIDIUM DIFFICILE COLITISLanguage of the patent:
English
Timeline
Today
1.2.2011EP application
6.4.2022EP Publication
3.6.2022Translation submitted
15.7.2022Registration published
31.1.2027Expires
Owner
Name:
Ferring Microbiome Inc.Address:
2660 Patton Road, Roseville, Minnesota 55113, US
Inventor
Name:
HLAVKA, Edwin J.Address:
Minneapolis, MN 55405, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
33728310 PDate:
1.2.2010Country:
US
Number:
35118410 PDate:
3.6.2010Country:
US
Classification
Categories:
C12N 1/04, A61K 35/741, A61K 35/74, A61K 9/20, G01N 33/569, C12N 1/20, A61P 1/00, A61P 1/12, A61P 31/04
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 22.2.2023
Expires: 31.1.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 29.2.2024
Expires: 31.1.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 14.2.2025
Expires: 31.1.2026
Payer: Árnason Faktor ehf.
Number: 16
Paid: 23.2.2026
Expires: 31.1.2027
Payer: Árnason Faktor ehf.